US Stock MarketDetailed Quotes
FMS Fresenius Medical Care
- 23.870
- -0.030-0.13%
Close Dec 11 16:00 ET
14.01BMarket Cap20.21P/E (TTM)
23.940High23.730Low204.11KVolume23.900Open23.900Pre Close4.87MTurnover0.05%Turnover Ratio26.76P/E (Static)586.83MShares24.31052wk High0.98P/B9.50BFloat Cap17.79452wk Low0.66Dividend TTM397.82MShs Float51.648Historical High2.77%Div YieldTTM0.88%Amplitude0.515Historical Low23.849Avg Price1Lot Size
Fresenius Medical Care Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -56.11%442M | -10.87%127.31M | 21.29%2.63B | 34.09%1.01B | -10.00%142.84M | -12.94%2.17B | -10.37%599.66M | |||
| Net income from continuing operations | 79.59%264M | 23.59%241M | -11.61%118.32M | -18.10%732.46M | 32.48%256.46M | -48.04%147M | -5.34%195M | -36.80%133.85M | -26.64%894.33M | -36.27%193.58M |
| Operating gains losses | ---- | ---- | 24.72%-40.21M | 18.78%-134.69M | ---- | ---- | ---- | -278.21%-53.41M | -244.85%-165.83M | -206.21%-52.01M |
| Depreciation and amortization | ---- | -10.83%387M | 17.05%512.44M | -4.70%1.75B | ---- | ---- | 2.84%434M | 4.50%437.81M | 13.22%1.84B | 13.17%494.67M |
| Deferred tax | ---- | ---- | -98.30%-44.37M | -194.54%-122.15M | ---- | ---- | ---- | -140.70%-22.37M | -161.66%-41.47M | -76.76%18.61M |
| Other non cash items | 17.62%721M | ---- | 6.80%88.19M | 15.03%336.42M | -1,557.32%-1.1B | 701.46%613M | ---- | 19.50%82.57M | 4.30%292.48M | 12.90%75.32M |
| Change In working capital | ---- | -149.21%-186M | -24.63%-420.83M | 538.27%561.28M | ---- | ---- | 207.32%378M | 17.18%-337.67M | -30.99%-128.07M | 142.06%56.11M |
| -Change in receivables | 645.88%464M | -107.06%-23M | -54.89%-552.72M | -225.27%-151.84M | 449.89%13.16M | -324.26%-85M | 84.18%326M | -42.46%-356.85M | 71.40%-46.68M | 94.87%-3.76M |
| -Change in inventory | 23.64%68M | 31.82%-15M | 53.62%-41M | 93.57%-13.14M | 221.65%42.86M | 208.42%55M | 60.71%-22M | -42.44%-88.39M | -320.99%-204.31M | -133.52%-35.23M |
| -Change in payables and accrued expense | ---- | ---- | 64.90%190.81M | 1,966.22%580.56M | ---- | ---- | ---- | 175.63%115.72M | 38.08%-31.11M | 59.99%-78.99M |
| -Change in other current assets | ---- | ---- | -120.04%-17.93M | -5.41%145.7M | ---- | ---- | ---- | -114.08%-8.15M | -6.19%154.03M | 440.17%174.09M |
| -Change in other working capital | ---- | -300.00%-148M | ---- | ---- | ---- | ---- | 3,600.00%74M | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 29.61%985M | -56.11%442M | -10.87%127.31M | 21.29%2.63B | 19.87%718.8M | 15.57%760M | 34.09%1.01B | -10.00%142.84M | -12.94%2.17B | -10.37%599.66M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 1.29%-306M | 58.13%-68.37M | 25.93%-544.23M | 8.28%-310M | 22.73%-163.28M | 38.58%-734.73M | 46.80%-224.95M | |||
| Capital expenditure reported | -26.87%-170M | 1.29%-153M | ---- | ---- | ---- | ---134M | 8.28%-155M | ---- | ---- | ---- |
| Net PPE purchase and sale | ---- | 1.29%-153M | 7.83%-129.49M | 2.81%-668.46M | ---- | ---- | 8.28%-155M | 12.11%-140.49M | 17.13%-687.78M | 24.83%-201.98M |
| Net business purchase and sale | ---- | ---- | 402.71%40.58M | 13,226.75%137M | ---- | ---- | ---- | 136.25%8.07M | 100.27%1.03M | 86.34%-15.53M |
| Net investment purchase and sale | ---- | ---- | 166.59%20.55M | 73.38%-12.77M | ---- | ---- | ---- | -5.69%-30.86M | -410.79%-47.97M | 81.60%-7.43M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | 1.29%-306M | 58.13%-68.37M | 25.93%-544.23M | ---- | ---- | 8.28%-310M | 22.73%-163.28M | 38.58%-734.73M | 46.80%-224.95M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -14,482.17%-289.66M | -14.91%-1.86B | 100.76%2.01M | -57.89%-1.62B | 66.46%-119.92M | |||||
| Net issuance payments of debt | ---- | ---- | -245.43%-514.14M | -23.08%-1.26B | ---- | ---- | ---- | 79.66%-148.84M | -185.05%-1.02B | 81.41%-53.45M |
| Cash dividends paid | ---- | ---- | ---- | 16.92%-328.62M | ---- | ---- | ---- | ---- | -0.79%-395.56M | --0 |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 209.52%20.15M | -99.60%2K |
| Net other financing activities | ---- | ---- | 48.81%224.48M | -23.68%-270.75M | ---- | ---- | ---- | -67.50%150.85M | 21.69%-218.91M | 5.78%-66.46M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | ---- | -14,482.17%-289.66M | -14.91%-1.86B | ---- | ---- | ---- | 100.76%2.01M | -57.89%-1.62B | 66.46%-119.92M |
| Net cash flow | ||||||||||
| Beginning cash position | ---- | ---- | 12.05%1.43B | -14.03%1.27B | ---- | ---- | ---- | -14.03%1.27B | 37.00%1.48B | -28.70%1.11B |
| Current changes in cash | ---- | ---- | -1,151.99%-230.72M | 222.38%226.05M | ---- | ---- | ---- | 94.23%-18.43M | -168.69%-184.71M | 328.98%254.8M |
| Effect of exchange rate changes | ---- | ---- | 85.66%-4.51M | -213.47%-72.61M | ---- | ---- | ---- | -387.47%-31.47M | -117.65%-23.16M | -404.09%-94.56M |
| End cash Position | ---- | ---- | -2.61%1.19B | 12.05%1.43B | ---- | ---- | ---- | 4.31%1.22B | -14.03%1.27B | -14.03%1.27B |
| Free cash flow | 31.90%645M | -81.35%130M | -1,036.36%-6.59M | 34.70%1.94B | 142.58%898.21M | -1.66%489M | 70.00%697M | 120.77%704K | -11.73%1.44B | -8.09%370.28M |
| Currency Unit | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data